Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data

Background Electrocardiographic QT interval prolongation is the most widely used risk marker for ventricular arrhythmia potential and thus an important component of drug cardiotoxicity assessments. Several antimalarial medicines are associated with QT interval prolongation. However, interpretation o...

Full description

Bibliographic Details
Main Authors: Chan, XHS, Win, YN, Haeusler, IL, Tan, JY, Loganathan, S, Saralamba, S, Chan, SKS, Ashley, EA, Barnes, KI, Baiden, R, Bassi, PU, Djimde, A, Dorsey, G, Duparc, S, Hanboonkunupakarn, B, ter Kuile, FO, Lacerda, MVG, Nasa, A, Nosten, FH, Onyeji, CO, Pukrittayakamee, S, Siqueira, AM, Tarning, J, Taylor, WRJ, Valentini, G, van Vugt, M, Wesche, D, Day, NPJ, Huang, CL-H, Brugada, J, Price, RN, White, NJ
Format: Journal article
Language:English
Published: Public Library of Science (PLoS) 2020
_version_ 1797098257576361984
author Chan, XHS
Win, YN
Haeusler, IL
Tan, JY
Loganathan, S
Saralamba, S
Chan, SKS
Ashley, EA
Barnes, KI
Baiden, R
Bassi, PU
Djimde, A
Dorsey, G
Duparc, S
Hanboonkunupakarn, B
ter Kuile, FO
Lacerda, MVG
Nasa, A
Nosten, FH
Onyeji, CO
Pukrittayakamee, S
Siqueira, AM
Tarning, J
Taylor, WRJ
Valentini, G
van Vugt, M
Wesche, D
Day, NPJ
Huang, CL-H
Brugada, J
Price, RN
White, NJ
author_facet Chan, XHS
Win, YN
Haeusler, IL
Tan, JY
Loganathan, S
Saralamba, S
Chan, SKS
Ashley, EA
Barnes, KI
Baiden, R
Bassi, PU
Djimde, A
Dorsey, G
Duparc, S
Hanboonkunupakarn, B
ter Kuile, FO
Lacerda, MVG
Nasa, A
Nosten, FH
Onyeji, CO
Pukrittayakamee, S
Siqueira, AM
Tarning, J
Taylor, WRJ
Valentini, G
van Vugt, M
Wesche, D
Day, NPJ
Huang, CL-H
Brugada, J
Price, RN
White, NJ
author_sort Chan, XHS
collection OXFORD
description Background Electrocardiographic QT interval prolongation is the most widely used risk marker for ventricular arrhythmia potential and thus an important component of drug cardiotoxicity assessments. Several antimalarial medicines are associated with QT interval prolongation. However, interpretation of electrocardiographic changes is confounded by the coincidence of peak antimalarial drug concentrations with recovery from malaria. We therefore reviewed all available data to characterise the effects of malaria disease and demographic factors on the QT interval in order to improve assessment of electrocardiographic changes in the treatment and prevention of malaria. Methods and findings We conducted a systematic review and meta-analysis of individual patient data. We searched clinical bibliographic databases (last on August 21, 2017) for studies of the quinoline and structurally related antimalarials for malaria-related indications in human participants in which electrocardiograms were systematically recorded. Unpublished studies were identified by the World Health Organization (WHO) Evidence Review Group (ERG) on the Cardiotoxicity of Antimalarials. Risk of bias was assessed using the Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) checklist for adverse drug events. Bayesian hierarchical multivariable regression with generalised additive models was used to investigate the effects of malaria and demographic factors on the pretreatment QT interval. The meta-analysis included 10,452 individuals (9,778 malaria patients, including 343 with severe disease, and 674 healthy participants) from 43 studies. 7,170 (68.6%) had fever (body temperature ≥ 37.5°C), and none developed ventricular arrhythmia after antimalarial treatment. Compared to healthy participants, patients with uncomplicated falciparum malaria had shorter QT intervals (−61.77 milliseconds; 95% credible interval [CI]: −80.71 to −42.83) and increased sensitivity of the QT interval to heart rate changes. These effects were greater in severe malaria (−110.89 milliseconds; 95% CI: −140.38 to −81.25). Body temperature was associated independently with clinically significant QT shortening of 2.80 milliseconds (95% CI: −3.17 to −2.42) per 1°C increase. Study limitations include that it was not possible to assess the effect of other factors that may affect the QT interval but are not consistently collected in malaria clinical trials. Conclusions Adjustment for malaria and fever-recovery–related QT lengthening is necessary to avoid misattributing malaria-disease–related QT changes to antimalarial drug effects. This would improve risk assessments of antimalarial-related cardiotoxicity in clinical research and practice. Similar adjustments may be indicated for other febrile illnesses for which QT-interval–prolonging medications are important therapeutic options.
first_indexed 2024-03-07T05:06:58Z
format Journal article
id oxford-uuid:da420f2c-56dd-4007-ac77-84d225ddbc60
institution University of Oxford
language English
last_indexed 2024-03-07T05:06:58Z
publishDate 2020
publisher Public Library of Science (PLoS)
record_format dspace
spelling oxford-uuid:da420f2c-56dd-4007-ac77-84d225ddbc602022-03-27T09:02:03ZFactors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient dataJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:da420f2c-56dd-4007-ac77-84d225ddbc60EnglishSymplectic ElementsPublic Library of Science (PLoS)2020Chan, XHSWin, YNHaeusler, ILTan, JYLoganathan, SSaralamba, SChan, SKSAshley, EABarnes, KIBaiden, RBassi, PUDjimde, ADorsey, GDuparc, SHanboonkunupakarn, Bter Kuile, FOLacerda, MVGNasa, ANosten, FHOnyeji, COPukrittayakamee, SSiqueira, AMTarning, JTaylor, WRJValentini, Gvan Vugt, MWesche, DDay, NPJHuang, CL-HBrugada, JPrice, RNWhite, NJBackground Electrocardiographic QT interval prolongation is the most widely used risk marker for ventricular arrhythmia potential and thus an important component of drug cardiotoxicity assessments. Several antimalarial medicines are associated with QT interval prolongation. However, interpretation of electrocardiographic changes is confounded by the coincidence of peak antimalarial drug concentrations with recovery from malaria. We therefore reviewed all available data to characterise the effects of malaria disease and demographic factors on the QT interval in order to improve assessment of electrocardiographic changes in the treatment and prevention of malaria. Methods and findings We conducted a systematic review and meta-analysis of individual patient data. We searched clinical bibliographic databases (last on August 21, 2017) for studies of the quinoline and structurally related antimalarials for malaria-related indications in human participants in which electrocardiograms were systematically recorded. Unpublished studies were identified by the World Health Organization (WHO) Evidence Review Group (ERG) on the Cardiotoxicity of Antimalarials. Risk of bias was assessed using the Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) checklist for adverse drug events. Bayesian hierarchical multivariable regression with generalised additive models was used to investigate the effects of malaria and demographic factors on the pretreatment QT interval. The meta-analysis included 10,452 individuals (9,778 malaria patients, including 343 with severe disease, and 674 healthy participants) from 43 studies. 7,170 (68.6%) had fever (body temperature ≥ 37.5°C), and none developed ventricular arrhythmia after antimalarial treatment. Compared to healthy participants, patients with uncomplicated falciparum malaria had shorter QT intervals (−61.77 milliseconds; 95% credible interval [CI]: −80.71 to −42.83) and increased sensitivity of the QT interval to heart rate changes. These effects were greater in severe malaria (−110.89 milliseconds; 95% CI: −140.38 to −81.25). Body temperature was associated independently with clinically significant QT shortening of 2.80 milliseconds (95% CI: −3.17 to −2.42) per 1°C increase. Study limitations include that it was not possible to assess the effect of other factors that may affect the QT interval but are not consistently collected in malaria clinical trials. Conclusions Adjustment for malaria and fever-recovery–related QT lengthening is necessary to avoid misattributing malaria-disease–related QT changes to antimalarial drug effects. This would improve risk assessments of antimalarial-related cardiotoxicity in clinical research and practice. Similar adjustments may be indicated for other febrile illnesses for which QT-interval–prolonging medications are important therapeutic options.
spellingShingle Chan, XHS
Win, YN
Haeusler, IL
Tan, JY
Loganathan, S
Saralamba, S
Chan, SKS
Ashley, EA
Barnes, KI
Baiden, R
Bassi, PU
Djimde, A
Dorsey, G
Duparc, S
Hanboonkunupakarn, B
ter Kuile, FO
Lacerda, MVG
Nasa, A
Nosten, FH
Onyeji, CO
Pukrittayakamee, S
Siqueira, AM
Tarning, J
Taylor, WRJ
Valentini, G
van Vugt, M
Wesche, D
Day, NPJ
Huang, CL-H
Brugada, J
Price, RN
White, NJ
Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data
title Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data
title_full Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data
title_fullStr Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data
title_full_unstemmed Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data
title_short Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data
title_sort factors affecting the electrocardiographic qt interval in malaria a systematic review and meta analysis of individual patient data
work_keys_str_mv AT chanxhs factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT winyn factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT haeusleril factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT tanjy factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT loganathans factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT saralambas factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT chansks factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT ashleyea factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT barneski factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT baidenr factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT bassipu factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT djimdea factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT dorseyg factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT duparcs factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT hanboonkunupakarnb factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT terkuilefo factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT lacerdamvg factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT nasaa factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT nostenfh factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT onyejico factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT pukrittayakamees factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT siqueiraam factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT tarningj factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT taylorwrj factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT valentinig factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT vanvugtm factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT wesched factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT daynpj factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT huangclh factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT brugadaj factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT pricern factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata
AT whitenj factorsaffectingtheelectrocardiographicqtintervalinmalariaasystematicreviewandmetaanalysisofindividualpatientdata